Searched for
DATLA
Savitri Jindal tops again, Biological E's Mahima Datla joins Forbes' rich list; Here are top nine richest womenIndia's wealthiest list sees nine women featured in 2024, led by Savitri Jindal with a net worth of $43.7 billion. Notable names include Re...- Corbevax vaccine gets WHO Emergency Use Listing authorisationThe company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, ...
- Biological E plans to hive off non-vaccine business and sell stakeAccording to rating firm ICRA, BE reported revenues of Rs 2,556.8 crore in FY22, largely driven by the government's Rs 1,500-crore contract...
- BE's pediatric pneumonia jab gets CDSCO expert panel approvalThe BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infecti...
- Biological E to invest Rs 1800 crore to augment vaccine capacity, injectables, R&DAccording to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- Corbevax to cost Rs 800 in market & Rs 145 for the govt"Our price to the government programme is ₹145, the lowest in the country and possibly the world," Datla said. "It's something we take grea...
- New Covid vaccine: Bio E may submit Corbevax trial data this monthThe government had estimated that Biological would account for 300 million jabs from August to December.
- BE hopes to roll out COVID-19 vaccine Corbevax by November-endSpeaking to reporters on the sidelines of signing a financing agreement with US International Development Finance Corporation (DFC), she sa...
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
- Biological E plans to break into the big league by manufacturing three Covid-19 vaccinesOf these, the phase-three trials of Corbevax — jointly manufactured by BE, Baylor College of Medicine in Houston and Dynavax in California ...
- Tata Trusts to double spending on sports to Rs 100 croreThe trusts will set aside as much as Rs 100 crore annually by 2022 toward sports such as archery, kabaddi, hockey, football and badminton.
- More jabs on way: Three candidates to file final data, launch phase-3 trialsBiological E, Dr Reddy’s Laboratories and Serum Institute of India are preparing to submit data for approval of their Covid-19 vaccines or ...
- Indian vaccine makers say can quickly adapt to tackle variantsIn all, India has reported more than 11 million coronavirus infections, the highest number in the world after the United States, and about ...
- Vaccine capital: Spotlight on Hyderabad; city set to produce a third of the world's dosageBe it India’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FluGen’s CoroFlu ...
- India seems to be getting closer to an antidote, even as the coronavirus situation worsensThis week India overtook the US in daily addition of new COVID-19 cases. It is worrying. The World Health Organization says that the infect...
- Indian companies making Covid-19 vaccine upset over lack of norms and infrastructureIndia is staring at the risk of losing its competitive advantage in vaccine manufacturing to other countries, Biological E chairperson said...
- Koepka Brooks no quarter to Tiger WoodsBecomes first player to win US Open and PGA Championship in the same year since Woods in 2000.
- IBA releases ICSI guidance note on diligence reportIndian Banks Association has released a guidance note on diligence report for banks, prepared by Institute of Company Secretaries of India ...
- Elico's technological competenceTechnological competency is at the heart of Elico’s success. Thanks to its focus on research and development, the company has become one of...
Load More
